Info on off-label use is here.
http://www.fda.gov/ForPatients/Other/OffLabel/default.htm
I'm not sure if off-label use would be covered by insurance and/or funding by states, which is vital for orphan drug use given the high cost per treatment.
Dementia, page-5
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.25 |
Change
-1.400(7.51%) |
Mkt cap ! $2.186B | |||
| Open | High | Low | Value | Volume |
| $18.15 | $18.18 | $16.87 | $5.956M | 345.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 240 | $17.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.25 | 211 | 12 |
View Market Depth
| Last trade - 11.08am 05/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |